ISSN : 2347-5447
Inflammatory breast cancer is aggressive type of breast cancer characterized by rapidly enlarge tender, firm, erythematous breast, often without distinct palpable mass. The changes that appears on the skin are resembles to inflammation and it differs from other forms of breast cancer regarding its symptoms, prognosis, and treatment. It account for approximately 2–5% of rest of the breast cancers. It has hazardous course with a low 5-years survival rate. Management includes psychosocial support, the preoperative chemotherapy, radiation therapy and mastectomy. In the present review the epidemiology, clinical presentation and the management options of inflammatory breast cancer are summarized.
British Biomedical Bulletin received 971 citations as per Google Scholar report